Whitehawk Therapeutics, Inc. Common Stock (WHWK) is a publicly traded Healthcare sector company. As of September 6, 2026, WHWK trades at $4.60 with a market cap of $262.24M and a P/E ratio of -13.92. WHWK moved -0.65% today. Year to date, WHWK is +88.52%; over the trailing twelve months it is +152.75%. Its 52-week range spans $1.39 to $5.50. Analyst consensus is strong buy with an average price target of $8.25. Rallies surfaces WHWK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest WHWK news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $4.60 |
| Market Cap | $262.24M |
| P/E Ratio | -13.92 |
| EPS | $-0.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.50 |
| 52-Week Low | $1.39 |
| Volume | 150.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.14M |
| Net Income | $-20.60M |
| Gross Margin | 89.36% |
5 analysts cover WHWK: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.25.